Provided by Tiger Trade Technology Pte. Ltd.

LandBridge Co. LLC

74.50
+0.06000.08%
Post-market: 75.000.5000+0.67%17:18 EST
Volume:981.48K
Turnover:72.99M
Market Cap:5.74B
PE:100.46
High:75.45
Open:74.98
Low:72.79
Close:74.44
52wk High:87.60
52wk Low:43.75
Shares:77.09M
Float Shares:56.95M
Volume Ratio:1.67
T/O Rate:1.72%
Dividend:0.40
Dividend Rate:0.54%
EPS(TTM):0.7416
EPS(LYR):0.0721
ROE:11.32%
ROA:7.24%
PB:21.12
PE(LYR):1,033.29

Loading ...

Stock Track | LandBridge (LB) Plunges 5.17% Pre-Market After Significant Q3 Earnings Miss

Stock Track
·
Nov 13, 2025

Stock Track | LandBridge Plummets 5.17% Pre-Market on Earnings Miss

Stock Track
·
Nov 13, 2025

LandBridge Q3 Sales $50.831M Miss $51.807M Estimate

Benzinga
·
Nov 13, 2025

Earnings Flash (LB) LandBridge Posts Q3 Revenue $50.8M, vs. FactSet Est of $50.2M

MT Newswires Live
·
Nov 13, 2025

BRIEF-LandBridge Co LLC Q3 Revenue USD 50.8 Million Vs. IBES Estimate USD 51.8 Million

Reuters
·
Nov 13, 2025

LandBridge Company LLC reports third quarter revenue of $50.8 million and net income of $20.3 million

Reuters
·
Nov 13, 2025

Landbridge Co Llc Q3 Free Cash Flow USD 33.7 Million

THOMSON REUTERS
·
Nov 13, 2025

Landbridge Co Llc Q3 Adjusted Ebitda Margin 88%

THOMSON REUTERS
·
Nov 13, 2025

Landbridge Co Llc - Reaffirms Midpoint of FY Outlook, Adj Ebitda Expected to Be Between $165 Mln and $175 Mln

THOMSON REUTERS
·
Nov 13, 2025

Landbridge Co Llc Q3 Adjusted Ebitda USD 44.9 Million VS. Ibes Estimate USD 46.4 Million

THOMSON REUTERS
·
Nov 13, 2025

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 13, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners

Reuters
·
Nov 12, 2025

Stock Track | LandBridge Co. LLC (LB) Plummets 5.23% Following New Executive Appointment

Stock Track
·
Nov 12, 2025

LB Pharmaceuticals Appoints New Chief Commercial Officer

TIPRANKS
·
Nov 12, 2025

LB Pharmaceuticals appoints Kaya Pai Panandiker as CCO

TIPRANKS
·
Nov 12, 2025

Press Release: LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer

Dow Jones
·
Nov 12, 2025

LandBridge rises 9.3%

TIPRANKS
·
Nov 11, 2025

LB Pharmaceuticals Reports Strong Q3 and Strategic Progress

TIPRANKS
·
Nov 11, 2025

LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference

GlobeNewswire
·
Nov 07, 2025

LB Pharmaceuticals Q3 EPS $(0.61) Beats $(0.63) Estimate

Benzinga
·
Nov 06, 2025